Quarterly report pursuant to Section 13 or 15(d)

GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)

v3.21.2
GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 15, 2019
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Acquired Indefinite-lived Intangible Assets [Line Items]              
Goodwill   $ 8,433   $ 8,433   $ 8,433  
Amortization expense   $ 1,100 $ 1,100 $ 2,200 $ 2,200    
BioPharma Acquisition [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Finite-lived Intangible Assets Acquired $ 15,600            
Goodwill 8,300           $ 100
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles $ 7,300